Drug Type Small molecule drug |
Synonyms CD 10367, CD10367 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Psoriasis vulgaris | Phase 2 | France | 03 Nov 2016 | |
| Psoriasis | Phase 2 | France | 03 Nov 2016 | |
| Plaque psoriasis | Phase 2 | France | 12 Oct 2015 |
Phase 2 | 24 | placebo (CD10367 Placebo Pretreated) | szaxkoeane(knnmmgqryi) = vkulocuxkm gmskqmofdf (aytkqiczzb, 24.5) View more | - | 19 Sep 2024 | ||
(CD10367 3% Pretreated) | szaxkoeane(knnmmgqryi) = yakcqrbabg gmskqmofdf (aytkqiczzb, 22.5) View more |





